RVL Pharmaceuticals plc Quarterly Intangible Assets, Net (Excluding Goodwill) in USD from Q4 2016 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary
RVL Pharmaceuticals plc quarterly Intangible Assets, Net (Excluding Goodwill) history and growth rate from Q4 2016 to Q1 2023.
  • RVL Pharmaceuticals plc Intangible Assets, Net (Excluding Goodwill) for the quarter ending March 31, 2023 was $13.9M, a 48.9% decline year-over-year.
Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)
Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $13.9M -$13.3M -48.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $13.9M -$13.3M -48.9% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $27.2M $0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $27.2M $0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $27.2M -$35.9M -56.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $27.2M -$7.88M -22.5% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $27.2M -$90.7M -76.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $27.2M -$114M -80.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $63.1M -$86.5M -57.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $35.1M -$28.9M -45.2% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $118M -$71.4M -37.7% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $142M -$189M -57.2% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $150M -$324M -68.4% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $64M -$19.7M -23.5% Dec 31, 2019 10-Q 2021-11-15
Q3 2019 $189M -$332M -63.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $331M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $474M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $83.7M -$502M -85.7% Dec 31, 2018 8-K 2021-09-08
Q3 2018 $521M Sep 30, 2018 10-Q 2018-11-08
Q4 2017 $585M -$116M -16.5% Dec 31, 2017 10-K 2020-03-19
Q4 2016 $701M Dec 31, 2016 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.